Display Settings:

Format

Send to:

Choose Destination
Health Qual Life Outcomes. 2009 Jun 5;7:52. doi: 10.1186/1477-7525-7-52.

Health-related quality of life of Southern Chinese with chronic hepatitis B infection.

Author information

  • 1Department of Medicine (Family Medicine Unit), The University of Hong Kong, Ap Lei Chau Clinic, Ap Lei Chau, Hong Kong. etplam@gmail.com

Abstract

BACKGROUND:

Few studies have evaluated the health-related quality of life (HRQOL) of Southern Chinese with chronic hepatitis B (CHB) infection.

AIM:

To evaluate the HRQOL of Chinese patients at different stages of CHB infection and to find out factors associated with HRQOL.

METHODS:

520 Chinese adult CHB patients of whom 156 were uncomplicated, 102 had impaired liver function, 139 had cirrhosis and 123 had hepatocellular carcinoma (HCC) were interviewed with a structured questionnaire, the SF-36 Health Survey version 2 (SF-36v2), and the Chronic Liver Disease Questionnaire (CLDQ). The differences in SF-6D health preference values and SF-36v2 scores between each CHB group and Hong Kong population norms were assessed by t-test. ANOVA was used to compare the mean SF-6D health preference, SF-36v2 scores, and CLDQ scores among CHB groups. Multiple linear regressions were performed to identify determinants of HRQOL.

RESULTS:

CHB patients had significantly lower SF-36v2 scores than the population norm. The SF-6D values of CHB patients with uncomplicated disease, impaired liver function, HCC and cirrhosis were 0.755, 0.745, 0.720 and 0.701, respectively, all significantly lower than the population norm of 0.787. Advanced stage of CHB illness, anti-viral treatment, bilirubin level, psychological co-morbidity, younger age and female were associated with poorer HRQOL.

CONCLUSION:

CHB infection had a negative impact on HRQOL. There was a progressive decrease in health preference values with CHB disease progression. The results can be used for the estimation of quality adjusted life years (QALYs) for CHB patients in cost effectiveness or cost utility studies.

TRIAL REGISTRATION:

http://www.hkclinicaltrials.com; HKCTR-151.

PMID:
19500349
[PubMed - indexed for MEDLINE]
PMCID:
PMC2701941
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk